Susan D. Richman - Concepedia

Author

Susan D. Richman

Also Known As

Richman, SD, Richman, Susan D., S D Richman, S RICHMAN, S Richman, S. D. Richman, S. Richman, S.D. Richman, SD Richman, SUSAN RICHMAN

315

Publications

6.3K

Citations

H-Index

Concepts

All Affiliations

University of Leeds University of Oxford St James's University Hospital University College London Queen's University Belfast

About

Susan D. Richman is an author at University of Leeds specializing in medicine, colorectal cancer, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	679
2	Health Sciences	3	3	91
3	Engineering	2	2	46
4	Public Health	2	2	148
5	Biostatistics	2	2	145

Susan D. Richman

Publications

5.7K

Citations

H-Index

Page 1

	Year	Citations
Mismatch Repair Status and <i>BRAF</i> Mutation Status in Metastatic Colorectal Cancer Patients: A Pooled Analysis of the CAIRO, CAIRO2, COIN, and FOCUS Studies Sabine Venderbosch, Irıs D. Nagtegaal, Tim Maughan, Clinical Cancer Research	2014	725
Value of Mismatch Repair, <i>KRAS</i> , and <i>BRAF</i> Mutations in Predicting Recurrence and Benefits From Chemotherapy in Colorectal Cancer Gordon Hutchins, Katie Southward, Kelly Handley, Journal of Clinical Oncology	2011	675
<i>KRAS</i> and <i>BRAF</i> Mutations in Advanced Colorectal Cancer Are Associated With Poor Prognosis but Do Not Preclude Benefit From Oxaliplatin or Irinotecan: Results From the MRC FOCUS Trial Susan D. Richman, Philip Chambers, Faye Elliott, Journal of Clinical Oncology	2009	567
Panitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): a prospectively stratified randomised trial Sarah Brown, Gary Middleton, Tim Maughan, The Lancet Oncology	2013	388
Clinical-Grade Detection of Microsatellite Instability in Colorectal Tumors by Deep Learning Amelie Echle, Heike I. Grabsch, Philip Quirke, Gastroenterology	2020	356
Predictive Biomarkers of Chemotherapy Efficacy in Colorectal Cancer: Results From the UK MRC FOCUS Trial Michael Braun, Susan D. Richman, Philip Quirke, Journal of Clinical Oncology	2008	275
Image-based consensus molecular subtype (imCMS) classification of colorectal cancer using deep learning Korsuk Sirinukunwattana, Enric Domingo, Susan D. Richman, Gut	2020	258
<scp>HER2</scp> overexpression and amplification as a potential therapeutic target in colorectal cancer: analysis of 3256 patients enrolled in the <scp>QUASAR</scp>, <scp>FOCUS</scp> and <scp>PICCOLO</scp> colorectal cancer trials Susan D. Richman, Katie Southward, Philip Chambers, The Journal of Pathology	2015	231
Transformer-based biomarker prediction from colorectal cancer histology: A large-scale multicentric study Sophia J. Wagner, Daniel Reisenbüchler, Nicholas P. West, Cancer Cell	2023	216
Investigating the poor outcomes ofBRAF-mutant advanced colorectal cancer: analysis from 2530 patients in randomised clinical trials Jenny F. Seligmann, David J. Fisher, Christopher G. Smith, Annals of Oncology MedicineCancer ManagementRandomised Clinical TrialsGastroenterologyPathology	2016	163

Page 1